The FDA proposed a new rule designed to determine both the safety and effectiveness of antibacterial hand soap and body washes.
Inga Beale, currently group chief executive of Canopius, will join Lloyd's in January 2014, the insurance market's chairman announced Dec. 16.
Security clearance for passengers will be transformed as pre-boarding security resources are allocated based on risk, the two organizations promise.
"In Jeh, our dedicated homeland security professionals will have a strong leader with a deep understanding of the threats we face and a proven ability to work across agencies and complex organizations to keep America secure," President Obama said in a White House statement.
The study found people with chronic obstructive pulmonary disease are about twice as likely to develop mild cognitive impairment.
Lucian Deacon is based in Denver and will manage the division's public outreach efforts.
The organizations sign a memorandum of understanding to promote global workplace safety efforts.
OSHA cites The Gilman Brothers Co. for over $105,000 in proposed safety violation fines.
The bus companies are shut down for various safety violations.
It requires accredited hospitals and critical access hospitals to improve the safety of their clinical alarm systems and is being implemented in two phases.
The “National Survey of Speeding Attitudes and Behaviors” finds nearly half of all drivers speed, among other conclusions.
The safety group has determined that at current levels, aspartame is safe to consume.
The agency is issuing a final guidance document that explains how animal pharmaceutical companies can work with it to voluntarily remove growth enhancement and feed efficiency indications from the approved uses of their medically important antimicrobial drug products.
The company released a five-point action plan Dec. 11 that will transition Canadian households that still receive mail at their doors to community mailboxes during the next five years. The plan allows attrition to reduce its employment by up to 8,000 positions.
The drug, which is currently the industry’s best hope for treating Alzheimer’s, moves to big trials.